Providers often only have a piece of the puzzle

Understanding both gene-drug and drug-drug interaction risk can help to avoid potentially harmful adverse drug events and help prevent adherence issues.

Up to 40% of people are poor or ultra rapid metabolizers of common medications based on their unique genotype. Click here

20-30% of potentially serious pharmacokinetic drug-drug interactions are often missed if you only focus on genotype. Click here

GenMedPro, the ultimate precision medicine software solution from Genomind, generates actionable recommendations grounded in patients' PGx testing outcomes. Say goodbye to healthcare providers frustrations with guesswork and trial-and-error approaches in prescribing. Embrace a new era of medication management with GenMedPro.

Click here to find out more!

Get a more complete understanding of your patient!

With access to critical metabolism, absorption, and sensitivity information, providers can fill critical data gaps and more easily optimize treatment.

Ben Weinstein, MD

Chair of Psychiatry, C. James and Carole Walter Looke Presidential Distinguished Centennial Clinical Academic Scholar in Behavioral Health, Houston Methodist.

For enquiries on Genomind, feel free to reach out to our sales representative at [email protected] or call +65 98254866